Bristol Myers Squibb gets USFDA accelerated nod for Breyanzi as CAR T Cell Therapy for adults with relapsed or refractory chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Susmita Roy15 March 2024 12:32 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Photobiomodulation offers safe and effective treatment for variety of skin conditions, says new research Medha Baranwal14 March 2024 11:45 PM ISTUSA: A recent medical education article published in the Journal of the American Academy of Dermatology reviews the various clinical applications of...
Novel oral hormone therapy promising for prostate cancer treatment with radiation therapy: JAMA Dr. Kamal Kant Kohli14 March 2024 11:15 PM ISTA high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center...
Rusfertide effective for controlling RBCs overproduction in polycythemia vera: NEJM Medha Baranwal14 March 2024 9:00 PM ISTUSA: A recent multi-centre clinical trial published in the New England Journal of Medicine has shed light on the efficacy and safety of rusfertide, a...
Maternal obesity may promote liver cancer among offsprings, reveals study Dr. Kamal Kant Kohli13 March 2024 11:00 PM ISTObesity, which could reach 50% of the population in certain developed countries by 2030, is a major public health concern. It not only affects the...
Delhi police crack down on fake cancer drug racket, seven arrested Ruchika Sharma13 March 2024 4:03 PM ISTNew Delhi: In a groundbreaking operation, the Delhi Police's crime branch has cracked down on a sprawling racket involved in the manufacturing and...
Elastography useful quantitative indicator of breast implant rupture risk: Study Medha Baranwal13 March 2024 3:45 AM ISTFrance: A recent study published in the Journal of Biomechanics has shown the usefulness of ultrasound elastography as a quantitative indicator of the...
High CRP in Metabolic Syndrome patients Linked to high Cancer Risk, finds study Dr Riya Dave12 March 2024 7:30 PM ISTMetabolic syndrome (MetS) has long been associated with an increased risk of cancer development. However, the dynamics of MetS over time and its...
Magnolia berry, fruit used in Chinese medicine, promising as treatment in colon cancer: Study Medha Baranwal12 March 2024 7:15 PM ISTUK: A new study published in ACS Pharmacology & Translational Science found that a fruit used in Chinese medicine contains a very effective...
Radiation therapy in breast cancer linked to increased risk of melanoma and hemangiosarcoma: JAMA Dr Riya Dave11 March 2024 8:00 PM ISTPrevious studies have suggested a potential link between radiation therapy for breast cancer and an increased risk of subsequent nonkeratinocyte skin...
MRI-Guided Focal Therapy Shows Promising 2-Year Outcomes for Intermediate-Risk Prostate Cancer: Study Dr Riya Dave11 March 2024 12:30 AM ISTProstate cancer is a common malignancy affecting men worldwide, and intermediate-risk prostate cancer (PCa) presents a challenging treatment scenario....
USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
